Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1184
-
Total 13F shares, excl. options
-
210M
-
Shares change
-
+1.58M
-
Total reported value, excl. options
-
$75.3B
-
Value change
-
+$617M
-
Put/Call ratio
-
1.16
-
Number of buys
-
523
-
Number of sells
-
-511
-
Price
-
$358.95
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q1 2021
1,325 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q1 2021.
Elevance Health, Inc. - Common Stock (ELV) has 1,184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 210M shares
of 226M outstanding shares and own 92.89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22.1M shares), VANGUARD GROUP INC (18.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.7M shares), WELLINGTON MANAGEMENT GROUP LLP (10.8M shares), STATE STREET CORP (10.4M shares), Capital International Investors (4.36M shares), BAILLIE GIFFORD & CO (3.92M shares), GEODE CAPITAL MANAGEMENT, LLC (3.79M shares), BANK OF AMERICA CORP /DE/ (3.72M shares), and ALLIANCEBERNSTEIN L.P. (3.7M shares).
This table shows the top 1184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.